Washington – October 16, 2026 -- Nearly half of patients with hormone receptor positive, HER2 negative advanced breast cancer develop resistance to first-line endocrine therapy driven by the ESR1 mutation (ESR1m), according to a new Academy of Managed Care Pharmacy (AMCP) Market Insights Program report. The report finds that biomarker testing and treatment paradigms are evolving faster than the evidence payers need to manage them.

Pittsburgh – October 16, 2026 -- Allegheny Health Network (AHN) Cancer Center has launched RANDY'S Trial, a clinical study funded by a gala that raised $44,000 in 2025, to test whether existing medications can break down fibrosis that blocks surgery in patients with appendiceal and other peritoneal cancers.

Jupiter, Florida – October 16, 2026 -- Myosin Therapeutics will present its first-in-class cancer candidate MT-125 at BioFuture 2026 in New York City on October 27–28, seeking investors and pharmaceutical partners to fund an extension into two additional treatment-resistant cancers.

MIAMI – October 16, 2026 -- Nicklaus Children's Hospital raised more than $4 million at its 19th Annual Diamond Ball on Saturday, October 10, funding the expansion of advanced specialized pediatric care for children and families across Florida and beyond.

Gala funds target specialized pediatric care expansion

The signature fundraising event drew community leaders, philanthropists, athletes and entertainment personalities. Radio co-hosts Enrique Santos and Dayanara Torres hosted the evening.

Lansing – October 16, 2026 -- Niowave is building an 80,000-square-foot medical radioisotope production facility in Lansing, Michigan, with a capital investment of more than $85 million and operations expected to start in 2028.

Labor Secretary Keith Sonderling toured Niowave's existing dedicated production facility and the construction site of its second plant. He also held a roundtable with company leaders on the production of medical radioisotopes for cancer treatments.

Los Angeles – October 16, 2026 -- Fengate Private Equity, a division of Fengate Asset Management, has partnered with Clinical Research of West Florida (CRWF), an independent trial site operator with more than 1,000 completed trials, in a deal with undisclosed terms.

Westcove Partners, LLC acted as exclusive financial advisor to CRWF. Its deal team comprised Managing Directors Justin Hand and Abe M'Bodj, Director Bill Bolding, Vice President Geno Catalano and Associate Andrew Hartono.

Alexandria, Va. – October 16, 2026 -- A wallet-sized CPR guidance patch from the University of Washington and a radiation-scatter device from the University of Pittsburgh School of Medicine took the $10,000 first prizes at the 2026 Collegiate Inventors Competition, which drew 25 students from nine U.S. colleges and universities.

London – October 16, 2026 -- The global ADHD drugs market will grow from USD 14.11 billion in 2025 to USD 22.79 billion by 2035, a compound annual growth rate of 4.91%, according to Credence Research Inc. The figures are the research firm's proprietary estimates, not audited sales totals.

North America holds 60% of value while Asia Pacific grows fastest at 6.34%

North America accounted for 60.0% of 2025 market value. Europe followed with 20.0%, Asia Pacific with 13.0%, Latin America with 4.0% and the Middle East and Africa with 3.0%.

Santa Barbara – October 16, 2026 -- Artera, a healthcare patient-communications provider, ranked No. 3,000 on the 2026 Inc. 5000 list of the fastest-growing private U.S. companies, reporting 102 percent three-year revenue growth and marking its seventh consecutive appearance.

Providence – October 16, 2026 -- Nabsys 2.0, LLC has released RepX, a cloud-based pipeline that can analyze up to 23 disease-associated repeat expansion loci in a single, low-cost run, according to the company.

RepX is available through the Nabsys Navigator cloud platform. It processes Electronic Genome Mapping (EGM) data generated on the OhmX Platform.